Literature DB >> 21301798

Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver.

Orestis Argyros1, Suet Ping Wong, Constantinos Fedonidis, Oleg Tolmachov, Simon N Waddington, Steven J Howe, Marcello Niceta, Charles Coutelle, Richard P Harbottle.   

Abstract

We have previously described the development of a scaffold/matrix attachment region (S/MAR) episomal vector system for in vivo application and demonstrated its utility to sustain transgene expression in the mouse liver for at least 6 months following a single administration. Subsequently, we observed that transgene expression is sustained for the lifetime of the animal. The level of expression, however, does drop appreciably over time. We hypothesised that by eliminating the bacterial components in our vectors, we could improve their performance since bacterial sequences have been shown to be responsible for the immunotoxicity of the vector and the silencing of its expression when applied in vivo. We describe here the development of a minimally sized S/MAR vector, which is devoid of extraneous bacterial sequences. This minicircle vector comprises an expression cassette and an S/MAR moiety, providing higher and more sustained transgene expression for several months in the absence of selection, both in vitro and in vivo. In contrast to the expression of our original S/MAR plasmid vector, the novel S/MAR minicircle vectors mediate increased transgene expression, which becomes sustained at about twice the levels observed immediately after administration. These promising results demonstrate the utility of minimally sized S/MAR vectors for persistent, atoxic gene expression.

Entities:  

Mesh:

Year:  2011        PMID: 21301798     DOI: 10.1007/s00109-010-0713-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  35 in total

Review 1.  Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements).

Authors:  J Bode; C Benham; A Knopp; C Mielke
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2000       Impact factor: 1.807

2.  An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo.

Authors:  Bok Hee C Jenke; Christian P Fetzer; Isa M Stehle; Franziska Jönsson; Frank O Fackelmayer; Harald Conradt; Jürgen Bode; Hans J Lipps
Journal:  EMBO Rep       Date:  2002-03-15       Impact factor: 8.807

3.  Performance of genomic bordering elements at predefined genomic loci.

Authors:  Sandra Goetze; Alexandra Baer; Silke Winkelmann; Kristina Nehlsen; Jost Seibler; Karin Maass; Jürgen Bode
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

4.  Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo.

Authors:  Efren Riu; Zhi-Ying Chen; Hui Xu; Chen-Yi He; Mark A Kay
Journal:  Mol Ther       Date:  2007-04-24       Impact factor: 11.454

5.  Inactive chromatin spreads from a focus of methylation.

Authors:  S U Kass; J P Goddard; R L Adams
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions.

Authors:  C Benham; T Kohwi-Shigematsu; J Bode
Journal:  J Mol Biol       Date:  1997-11-28       Impact factor: 5.469

Review 7.  Designing nonviral vectors for efficient gene transfer and long-term gene expression.

Authors:  Dean A Jackson; Stefan Juranek; Hans J Lipps
Journal:  Mol Ther       Date:  2006-06-19       Impact factor: 11.454

8.  Site-specific transgene integration in the human genome catalyzed by phiBT1 phage integrase.

Authors:  Li Chen; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2008-02       Impact factor: 5.695

9.  Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo.

Authors:  Z Y Chen; C Y He; L Meuse; M A Kay
Journal:  Gene Ther       Date:  2004-05       Impact factor: 5.250

10.  Nuclear-targeted minicircle to enhance gene transfer with non-viral vectors in vitro and in vivo.

Authors:  Laurence Vaysse; Lisa G Gregory; Richard P Harbottle; Eric Perouzel; Oleg Tolmachov; Charles Coutelle
Journal:  J Gene Med       Date:  2006-06       Impact factor: 4.565

View more
  18 in total

1.  Sustained gene expression in the retina by improved episomal vectors.

Authors:  Sofia M Calado; Ana V Oliveira; Susana Machado; Rudolf Haase; Gabriela A Silva
Journal:  Tissue Eng Part A       Date:  2014-05-09       Impact factor: 3.845

Review 2.  A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

Authors:  Adarsha Koirala; Shannon M Conley; Muna I Naash
Journal:  Biomaterials       Date:  2013-06-22       Impact factor: 12.479

Review 3.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

4.  Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liver.

Authors:  Hiu Man Viecelli; Richard P Harbottle; Suet Ping Wong; Andrea Schlegel; Marinee K Chuah; Thierry VandenDriessche; Cary O Harding; Beat Thöny
Journal:  Hepatology       Date:  2014-07-29       Impact factor: 17.425

Review 5.  The future of human DNA vaccines.

Authors:  Lei Li; Fadi Saade; Nikolai Petrovsky
Journal:  J Biotechnol       Date:  2012-09-07       Impact factor: 3.307

Review 6.  Gene therapy for heart failure: where do we stand?

Authors:  Charbel Naim; Armen Yerevanian; Roger J Hajjar
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

7.  Development and validation of non-integrative, self-limited, and replicating minicircles for safe reporter gene imaging of cell-based therapies.

Authors:  John A Ronald; Lorena Cusso; Hui-Yen Chuang; Xinrui Yan; Anca Dragulescu-Andrasi; Sanjiv Sam Gambhir
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

8.  Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modelling.

Authors:  Orestis Argyros; Suet Ping Wong; Kate Gowers; Richard Paul Harbottle
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

9.  Genetic modification of dividing cells using episomally maintained S/MAR DNA vectors.

Authors:  Suet-Ping Wong; Richard Paul Harbottle
Journal:  Mol Ther Nucleic Acids       Date:  2013-08-13       Impact factor: 10.183

10.  S/MAR sequence confers long-term mitotic stability on non-integrating lentiviral vector episomes without selection.

Authors:  Santhosh Chakkaramakkil Verghese; Natalya A Goloviznina; Amy M Skinner; Hans J Lipps; Peter Kurre
Journal:  Nucleic Acids Res       Date:  2014-01-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.